Epidemiologic studies demonstrate that the oral cavity of human adults is relatively resistant to HIV infection, and a number of soluble factors present in saliva have been postulated to confer this protection. In contrast, oral infection of infants who are breast fed by HIV-infected mothers is quite common, suggesting that there are age dependent differences in oral resistance to lentiviruses. We will investigate the basis of these age-dependent differences in antiviral resistance by characterizing anti-SIV innate immunity in the oral cavity of rhesus macaques. The long term goal of the proposed studies is to delineate the anti-HIV role of defensins, antiviral peptides now known to be present in saliva and expressed in epithelium of the oral cavity. Three human defensins were recently identified as anti-HIV factors produced by CD-8+ T cells from HIV-positive individuals who are long term non-progressors. We hypothesize that defensins conlribute to the anti-SIV/HW properties of saliva and to the innate resistance of oral mucosa, 2) that oral defensin expression develops postnatally, and 3) that the level of oral resistance to SIV in neonates may be augmented by topical application of one or more defensins. To test these hypotheses, we will pursue the following Specific Aims: ? Specific Aim 1 is to determine the level of alpha, beta,and theta-defensins present in saliva and/or expressed in the oral cavity of infant and adult rhesus macaques. ? Specific Aim 2 is to synthesize and/or recombinantly express specific alpha, beta, and theta-defensins confirmed (in Specific Aim 1) to be components of adult saliva and/or expressed in oral tissues. Peptides thus produced will be fully characterized and evaluated for their anti-SIV efficacy (Specific Aim 3), and will be used to produce anti-peptide immunologic reagents. ? Specific Aim 3 is to determine the anti-SIV and anti-HIV activities of oral alpha, beta,and theta-defensins in vitro. Anti-HW assays will be conducted with and without neonatal and adult saliva to ascertain the effect of this natural fluid on peptide activities. Combinations of peptides will also be analyzed to detect additive or synergistic pepfide-peptide interactions. ? Specific Aim 4 is to determine whether exogenous, topically administered defensin can alter the susceptibility to infection of neonatal rhesus macaques.

Agency
National Institute of Health (NIH)
Institute
National Institute of Dental & Craniofacial Research (NIDCR)
Type
Research Project (R01)
Project #
5R01DE015517-03
Application #
6994462
Study Section
Special Emphasis Panel (ZDE1-GH (75))
Program Officer
Rodriguez-Chavez, Isaac R
Project Start
2003-12-15
Project End
2007-11-30
Budget Start
2005-12-01
Budget End
2006-11-30
Support Year
3
Fiscal Year
2006
Total Cost
$559,660
Indirect Cost
Name
University of California Irvine
Department
Pathology
Type
Schools of Medicine
DUNS #
046705849
City
Irvine
State
CA
Country
United States
Zip Code
92697
Mastroianni, Jennifer R; Lu, Wuyuan; Selsted, Michael E et al. (2014) Differential Susceptibility of Bacteria to Mouse Paneth Cell ?-Defensins under Anaerobic Conditions. Antibiotics (Basel) 3:493-508
Rapireddy, Srinivas; Nhon, Linda; Meehan, Robert E et al. (2012) RTD-1mimic containing ?PNA scaffold exhibits broad-spectrum antibacterial activities. J Am Chem Soc 134:4041-4
Tongaonkar, Prasad; Tran, Patti; Roberts, Kevin et al. (2011) Rhesus macaque ?-defensin isoforms: expression, antimicrobial activities, and demonstration of a prominent role in neutrophil granule microbicidal activities. J Leukoc Biol 89:283-90
Schmidt, Nathan W; Mishra, Abhijit; Lai, Ghee Hwee et al. (2011) Criterion for amino acid composition of defensins and antimicrobial peptides based on geometry of membrane destabilization. J Am Chem Soc 133:6720-7
Seidel, Aprille; Ye, Ying; de Armas, Lesley R et al. (2010) Cyclic and acyclic defensins inhibit human immunodeficiency virus type-1 replication by different mechanisms. PLoS One 5:e9737
Park, Narae; Yamanaka, Kinrin; Tran, Dat et al. (2009) The cell-penetrating peptide, Pep-1, has activity against intracellular chlamydial growth but not extracellular forms of Chlamydia trachomatis. J Antimicrob Chemother 63:115-23
Tongaonkar, Prasad; Selsted, Michael E (2009) SDF2L1, a component of the endoplasmic reticulum chaperone complex, differentially interacts with {alpha}-, {beta}-, and {theta}-defensin propeptides. J Biol Chem 284:5602-9
Vasudevan, Sheeja; Yuan, Jun; Osapay, George et al. (2008) Synthesis, structure, and activities of an oral mucosal alpha-defensin from rhesus macaque. J Biol Chem 283:35869-77
Garcia, Angie E; Osapay, George; Tran, Patti A et al. (2008) Isolation, synthesis, and antimicrobial activities of naturally occurring theta-defensin isoforms from baboon leukocytes. Infect Immun 76:5883-91
Selsted, Michael E (2007) A pocket guide to explorations of the defensin field. Curr Pharm Des 13:3061-4